World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
100
Citations
30369
World Ranking
8359
National Ranking
4319

Artur V. Cideciyan publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Artur V. Cideciyan sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 376 publications — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Artur V. Cideciyan D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Artur V. Cideciyan sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 100 D-Index — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Artur V. Cideciyan is affiliated with the University of Pennsylvania in the United States. Their research primarily focuses on retinal development and disorders, with a significant body of work related to retinal diseases and treatments. The scientist's scholarly output spans the fields of medicine and biochemistry, genetics, and molecular biology, with publications also covering ophthalmology, molecular biology, cellular and molecular neuroscience, radiology, nuclear medicine and imaging, and genetics.

The main topics addressed in their research include:

  • Retinal Development and Disorders
  • Retinal Diseases and Treatments
  • Photoreceptor and Optogenetics Research
  • Glaucoma and Retinal Disorders
  • Ocular Disorders and Treatments
  • Retinal and Macular Surgery
  • Ophthalmology and Visual Impairment Studies

Among the frequently published venues where Artur V. Cideciyan's work appears are:

  • Translational Vision Science & Technology
  • American Journal of Ophthalmology
  • Investigative Ophthalmology & Visual Science
  • Vision Research
  • iScience

Frequent collaborators include:

  • Samuel G. Jacobson
  • Alexander Sumaroka
  • Alejandro J. Román
  • Małgorzata Świder
  • Alexandra V. Garafalo

Selected recent papers by Artur V. Cideciyan include:

  • Durable vision improvement after a single treatment with antisense oligonucleotide sepofarsen: a case report (2021, Nature Medicine)
  • Intravitreal antisense oligonucleotide sepofarsen in Leber congenital amaurosis type 10: a phase 1b/2 trial (2022, Nature Medicine)
  • Advancing Clinical Trials for Inherited Retinal Diseases: Recommendations from the Second Monaciano Symposium (2020, Translational Vision Science & Technology)
  • Full-field stimulus testing: Role in the clinic and as an outcome measure in clinical trials of severe childhood retinal disease (2021, Progress in Retinal and Eye Research)
  • Safety and improved efficacy signals following gene therapy in childhood blindness caused by GUCY2D mutations (2021, iScience)

Best Publications

  • Gene therapy restores vision in a canine model of childhood blindness.

    Gregory M. Acland;Gustavo D. Aguirre;Jharna Ray;Qi Zhang

  • Treatment of Leber Congenital Amaurosis Due to RPE65 Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I Trial

    William W. Hauswirth;Tomas S. Aleman;Shalesh Kaushal;Artur V. Cideciyan

  • Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics

    Artur V. Cideciyan;Tomas S. Aleman;Sanford L. Boye;Sharon B. Schwartz

  • Interim Results from the International Trial of Second Sight's Visual Prosthesis

    Mark S. Humayun;Jessy D. Dorn;Lyndon Da Cruz;Gislin Dagnelie

  • Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years

    Samuel G. Jacobson;Artur V. Cideciyan;Ramakrishna Ratnakaram;Elise Heon

  • Long-Term Restoration of Rod and Cone Vision by Single Dose rAAV-Mediated Gene Transfer to the Retina in a Canine Model of Childhood Blindness

    Gregory M. Acland;Gustavo D. Aguirre;Jean Bennett;Tomas S. Aleman

  • Mutation of a nuclear receptor gene, NR2E3, causes enhanced S cone syndrome, a disorder of retinal cell fate

    Neena B. Haider;Samuel G. Jacobson;Artur V. Cideciyan;Ruth Swiderski

  • Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement

    Artur V. Cideciyan;Samuel G. Jacobson;William A. Beltran;Alexander Sumaroka

  • Human RPE65 Gene Therapy for Leber Congenital Amaurosis: Persistence of Early Visual Improvements and Safety at 1 Year

    Artur V. Cideciyan;William W. Hauswirth;Tomas S. Aleman;Shalesh Kaushal

  • Improvement and decline in vision with gene therapy in childhood blindness.

    Samuel G. Jacobson;Artur V. Cideciyan;Alejandro J. Roman;Alexander Sumaroka

  • Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical Trial

    Lyndon da Cruz;Jessy D. Dorn;Mark S. Humayun;Gislin Dagnelie

  • Genetically engineered large animal model for studying cone photoreceptor survival and degeneration in retinitis pigmentosa

    Petters Rm;Alexander Ca;Wells Kd;Collins Eb

  • Psychophysical Evidence for Rod Vulnerability in Age-Related Macular Degeneration

    Cynthia Owsley;Gregory R. Jackson;Artur V. Cideciyan;Yijun Huang

  • Gene therapy rescues photoreceptor blindness in dogs and paves the way for treating human X-linked retinitis pigmentosa

    William A. Beltran;Artur V. Cideciyan;Alfred S. Lewin;Simone Iwabe

  • Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy.

    Artur V. Cideciyan

  • Disease sequence from mutant rhodopsin allele to rod and cone photoreceptor degeneration in man

    Artur V. Cideciyan;Donald C. Hood;Yijun Huang;Eyal Banin

  • Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina

    Jean Bennett;Albert M. Maguire;Artur V. Cideciyan;Michael Schnell

  • Rapid restoration of visual pigment and function with oral retinoid in a mouse model of childhood blindness.

    J. Preston Van Hooser;Tomas S. Aleman;Yu Guang He;Artur V. Cideciyan

  • Identifying photoreceptors in blind eyes caused by RPE65 mutations: Prerequisite for human gene therapy success

    Samuel G. Jacobson;Tomas S. Aleman;Artur V. Cideciyan;Alexander Sumaroka

  • Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence

    Artur V. Cideciyan;Tomas S. Aleman;Malgorzata Swider;Sharon B. Schwartz

Frequent Co-Authors

Samuel G. Jacobson
Samuel G. Jacobson University of Pennsylvania
Tomas S. Aleman
Tomas S. Aleman University of Pennsylvania
Edwin M. Stone
Edwin M. Stone University of Iowa
Gustavo D. Aguirre
Gustavo D. Aguirre University of Pennsylvania
William W. Hauswirth
William W. Hauswirth University of Florida
Sanford L. Boye
Sanford L. Boye University of Florida
Elise Héon
Elise Héon University of Toronto
Anand Swaroop
Anand Swaroop National Institutes of Health
Jean Bennett
Jean Bennett University of Pennsylvania
David G. Birch
David G. Birch The University of Texas Southwestern Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine opens up various pathways beyond becoming a physician. Today, online degree programs provide flexible and affordable options to help you advance in the healthcare field or pivot to related specialties.

For those interested in healthcare leadership, the most affordable online MHA programs offer a strong foundation in management and administration. If your goal is to practice medicine at the highest clinical level, consider exploring the least expensive DNP programs.

If pharmacy interests you, pharmacy school online options make it possible to earn a doctorate while balancing work and personal commitments. Additionally, technology-driven roles are booming, and a health information management bachelor degree online prepares you to manage healthcare data and inform decision-making processes.

No matter your interests, these flexible online degrees can enhance your skill set, improve your career prospects, and help meet the growing needs of the healthcare industry.

Best Scientists Citing Artur V. Cideciyan

Trending Scientists

Recently Published Articles